11,500 Shares in Inspire Medical Systems, Inc. $INSP Bought by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System purchased a new position in Inspire Medical Systems, Inc. (NYSE:INSP) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 11,500 shares of the company’s stock, valued at approximately $593,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of INSP. OP Asset Management Ltd bought a new position in shares of Inspire Medical Systems during the 1st quarter worth about $417,000. Assenagon Asset Management S.A. raised its stake in Inspire Medical Systems by 96.3% during the 1st quarter. Assenagon Asset Management S.A. now owns 520,174 shares of the company’s stock worth $26,831,000 after buying an additional 255,175 shares during the period. SG Americas Securities LLC boosted its holdings in Inspire Medical Systems by 173.5% in the first quarter. SG Americas Securities LLC now owns 105,147 shares of the company’s stock worth $5,423,000 after acquiring an additional 66,698 shares in the last quarter. Diversified Trust Co boosted its holdings in Inspire Medical Systems by 40.7% in the first quarter. Diversified Trust Co now owns 11,867 shares of the company’s stock worth $612,000 after acquiring an additional 3,435 shares in the last quarter. Finally, Rockefeller Capital Management L.P. grew its stake in Inspire Medical Systems by 14.9% in the fourth quarter. Rockefeller Capital Management L.P. now owns 5,712 shares of the company’s stock valued at $527,000 after acquiring an additional 739 shares during the period. 94.91% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on INSP shares. Wells Fargo & Company decreased their price objective on Inspire Medical Systems from $70.00 to $56.00 and set an “equal weight” rating for the company in a report on Tuesday, May 5th. Truist Financial decreased their price target on shares of Inspire Medical Systems from $64.00 to $50.00 and set a “hold” rating for the company in a research note on Tuesday, May 5th. Evercore downgraded shares of Inspire Medical Systems from an “outperform” rating to an “in-line” rating and set a $40.00 price objective on the stock. in a report on Tuesday, June 23rd. Royal Bank Of Canada lowered shares of Inspire Medical Systems from a “sector perform” rating to a “buy” rating in a research note on Monday, June 15th. Finally, Oppenheimer reiterated a “market perform” rating on shares of Inspire Medical Systems in a report on Monday, June 15th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, thirteen have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, Inspire Medical Systems has a consensus rating of “Hold” and an average target price of $81.05.

Inspire Medical Systems Trading Up 1.4%

Shares of Inspire Medical Systems stock opened at $50.14 on Wednesday. The stock has a fifty day simple moving average of $44.31 and a 200 day simple moving average of $61.08. Inspire Medical Systems, Inc. has a 12-month low of $38.91 and a 12-month high of $147.03. The company has a market capitalization of $1.44 billion, a P/E ratio of 11.17, a price-to-earnings-growth ratio of 5.01 and a beta of 0.71.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings data on Monday, May 4th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of ($0.28) by $0.38. The business had revenue of $204.58 million for the quarter, compared to analysts’ expectations of $200.04 million. Inspire Medical Systems had a return on equity of 10.35% and a net margin of 14.33%.The business’s revenue was up 1.6% on a year-over-year basis. During the same period last year, the business earned $0.10 EPS. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. On average, analysts predict that Inspire Medical Systems, Inc. will post 0.93 EPS for the current year.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.